$37.75
-0.81-2.10%
At Close: -
$37.75
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Amphastar Pharma
AMPHNASDAQ
want to know what
the Bulls & Bears Say?
Amphastar Pharma (NASDAQ:AMPH) Stock, Analyst Ratings, Price Targets, Forecasts
Amphastar Pharmaceuticals Inc has a consensus price target of $50.29 based on the ratings of 14 analysis. The 3 most-recent analyst ratings were released by Piper Sandler, JP Morgan, and B of A Securities on June 27, 2024, March 5, 2024, and November 17, 2023, respectively. With an average price target of $64.67 between Piper Sandler, JP Morgan, and B of A Securities, there's an implied 71.30% upside for Amphastar Pharmaceuticals Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Needham
JP Morgan
B of A Securities
Jefferies
1calculated from analyst ratings
Analyst Ratings for Amphastar Pharma
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/27/2024 | Buy Now | 88.08% | Piper Sandler | David Amsellem | $71 → $71 | Reiterates | Overweight → Overweight | Get Alert |
| 05/22/2024 | Buy Now | — | Needham | Serge Belanger | — | Reiterates | → Hold | Get Alert |
| 05/09/2024 | Buy Now | — | Needham | Serge Belanger | — | Reiterates | → Hold | Get Alert |
| 04/10/2024 | Buy Now | — | Needham | Serge Belanger | — | Reiterates | → Hold | Get Alert |
| 03/05/2024 | Buy Now | 58.94% | JP Morgan | Ekaterina Knyazkova | → $60 | Initiates | → Overweight | Get Alert |
| 11/17/2023 | Buy Now | 66.89% | B of A Securities | Jason Gerberry | → $63 | Initiates | → Neutral | Get Alert |
| 07/25/2023 | Buy Now | 85.43% | Jefferies | Glen Santangelo | → $70 | Reinstates | Buy → Buy | Get Alert |
| 05/17/2023 | Buy Now | 16.56% | Wells Fargo | Jacob Hughes | $40 → $44 | Maintains | Equal-Weight | Get Alert |
| 10/25/2022 | Buy Now | 5.96% | Piper Sandler | David Amsellem | $43 → $40 | Maintains | Overweight | Get Alert |
| 10/21/2022 | Buy Now | -4.64% | Jefferies | Glen Santangelo | — | Assumes | → Buy | Get Alert |
| 07/29/2022 | Buy Now | 16.56% | Capital One | Tim Chiang | → $44 | Initiates | → Overweight | Get Alert |
| 03/15/2022 | Buy Now | -15.23% | Wells Fargo | Jacob Hughes | $23 → $32 | Maintains | Equal-Weight | Get Alert |
| 03/11/2022 | Buy Now | -7.28% | Piper Sandler | David Amsellem | $28 → $35 | Maintains | Overweight | Get Alert |
| 01/07/2022 | Buy Now | -25.83% | Piper Sandler | David Amsellem | $21 → $28 | Upgrade | Neutral → Overweight | Get Alert |
FAQ
What is the target price for Amphastar Pharma (AMPH) stock?
The latest price target for Amphastar Pharma (NASDAQ:AMPH) was reported by Piper Sandler on June 27, 2024. The analyst firm set a price target for $71.00 expecting AMPH to rise to within 12 months (a possible 88.08% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Amphastar Pharma (AMPH)?
The latest analyst rating for Amphastar Pharma (NASDAQ:AMPH) was provided by Piper Sandler, and Amphastar Pharma reiterated their overweight rating.
When was the last upgrade for Amphastar Pharma (AMPH)?
The last upgrade for Amphastar Pharmaceuticals Inc happened on January 7, 2022 when Piper Sandler raised their price target to $28. Piper Sandler previously had a neutral for Amphastar Pharmaceuticals Inc.
When was the last downgrade for Amphastar Pharma (AMPH)?
There is no last downgrade for Amphastar Pharma.
When is the next analyst rating going to be posted or updated for Amphastar Pharma (AMPH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amphastar Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amphastar Pharma was filed on June 27, 2024 so you should expect the next rating to be made available sometime around June 27, 2025.
Is the Analyst Rating Amphastar Pharma (AMPH) correct?
While ratings are subjective and will change, the latest Amphastar Pharma (AMPH) rating was a reiterated with a price target of $71.00 to $71.00. The current price Amphastar Pharma (AMPH) is trading at is $37.75, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.